Abnormal error-related antisaccade activation in premanifest and early manifest Huntington disease
- PMID: 21401260
- PMCID: PMC3086952
- DOI: 10.1037/a0021873
Abnormal error-related antisaccade activation in premanifest and early manifest Huntington disease
Abstract
Objective: Individuals with the trinucleotide CAG expansion (CAG+) that causes Huntington's disease (HD) have impaired performance on antisaccade (AS) tasks that require directing gaze in the mirror opposite direction of visual targets. This study aimed to identify the neural substrates underlying altered antisaccadic performance.
Method: Three groups of participants were recruited: (1) Imminent and early manifest HD (early HD, n = 8); (2) premanifest (presymptomatic) CAG+ (preHD, n = 10); and (3) CAG unexpanded (CAG-) controls (n = 12). All participants completed a uniform study visit that included a neurological evaluation, neuropsychological battery, molecular testing, and functional MRI during an AS task. The blood oxygenation level dependent (BOLD) response was obtained during saccade preparation and saccade execution for both correct and incorrect responses using regression analysis.
Results: Significant group differences in BOLD response were observed when comparing incorrect AS to correct AS execution. Specifically, as the percentage of incorrect AS increased, BOLD responses in the CAG- group decreased progressively in a well-documented reward detection network that includes the presupplementary motor area and dorsal anterior cingulate cortex. In contrast, AS errors in the preHD and early HD groups lacked this relationship with BOLD signal in the error detection network, and BOLD responses to AS errors were smaller in the two CAG+ groups as compared with the CAG- group.
Conclusions: These results are the first to suggest that abnormalities in an error-related response network may underlie early changes in AS eye movements in premanifest and early manifest HD. (PsycINFO Database Record (c) 2011 APA, all rights reserved).
Figures





Similar articles
-
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.Lancet Neurol. 2013 Jul;12(7):637-49. doi: 10.1016/S1474-4422(13)70088-7. Epub 2013 May 9. Lancet Neurol. 2013. PMID: 23664844
-
Comparison of vertical and horizontal saccade measures and their relation to gray matter changes in premanifest and manifest Huntington disease.J Neurol. 2012 Feb;259(2):267-76. doi: 10.1007/s00415-011-6172-0. Epub 2011 Aug 18. J Neurol. 2012. PMID: 21850389 Free PMC article.
-
Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.J Neurol. 2009 Feb;256(2):203-12. doi: 10.1007/s00415-009-0052-x. Epub 2009 Mar 5. J Neurol. 2009. PMID: 19266143
-
Selective neurodegeneration, neuropathology and symptom profiles in Huntington's disease.Adv Exp Med Biol. 2012;769:141-52. doi: 10.1007/978-1-4614-5434-2_9. Adv Exp Med Biol. 2012. PMID: 23560309 Review.
-
[Functional imaging of cognitive processes in Huntington's disease and its presymptomatic mutation carriers].Nervenarzt. 2008 Apr;79(4):408-20. doi: 10.1007/s00115-007-2390-1. Nervenarzt. 2008. PMID: 18074113 Review. German.
Cited by
-
The diagnostic value of saccades in movement disorder patients: a practical guide and review.J Clin Mov Disord. 2015 Oct 15;2:14. doi: 10.1186/s40734-015-0025-4. eCollection 2015. J Clin Mov Disord. 2015. PMID: 26788350 Free PMC article. Review.
-
Eye movements in patients with neurodegenerative disorders.Nat Rev Neurol. 2013 Feb;9(2):74-85. doi: 10.1038/nrneurol.2012.273. Epub 2013 Jan 22. Nat Rev Neurol. 2013. PMID: 23338283 Review.
-
Neuroimaging biomarkers of neurodegenerative diseases and dementia.Semin Neurol. 2013 Sep;33(4):386-416. doi: 10.1055/s-0033-1359312. Epub 2013 Nov 14. Semin Neurol. 2013. PMID: 24234359 Free PMC article. Review.
-
Quantifying Motor Impairment in Movement Disorders.Front Neurosci. 2018 Apr 11;12:202. doi: 10.3389/fnins.2018.00202. eCollection 2018. Front Neurosci. 2018. PMID: 29695949 Free PMC article. Review.
-
Inhibitory control and working memory using saccadic eye movements in primary glaucoma.Atten Percept Psychophys. 2024 Oct;86(7):2374-2385. doi: 10.3758/s13414-024-02961-z. Epub 2024 Sep 26. Atten Percept Psychophys. 2024. PMID: 39327360
References
-
- Ali FR, Michell AW, Barker RA, Carpenter RH. The use of quantitative oculometry in the assessment of Huntington’s disease. Experimental Brain Research. 2006;169:237–245. - PubMed
-
- Amador N, Schlag-Rey M, Schlag J. Primate antisaccade. II. Supplementary eye field neuronal activity predicts correct performance. Journal of Neurophysiology. 2004;91:1672–1689. - PubMed
-
- Anderson EJ, Husain M, Sumner P. Human intraparietal sulcus (IPS) and competition between exogenous and endogenous saccade plans. Neuroimage. 2008;40:838–851. - PubMed
-
- Antoniades CA, Altham PM, Mason SL, Barker RA, Carpenter R. Saccadometry: a new tool for evaluating presymptomatic Huntington patients. Neuroreport. 2007;18:1133–1136. - PubMed
-
- Aylward EH, Brandt J, Codori AM, Mangus RS, Barta PE, Harris GJ. Reduced basal ganglia volume associated with the gene for Huntington’s disease in asymptomatic at-risk persons. Neurology. 1994;44:823–828. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials